ATE134880T1 - Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen - Google Patents
Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinenInfo
- Publication number
- ATE134880T1 ATE134880T1 AT89904944T AT89904944T ATE134880T1 AT E134880 T1 ATE134880 T1 AT E134880T1 AT 89904944 T AT89904944 T AT 89904944T AT 89904944 T AT89904944 T AT 89904944T AT E134880 T1 ATE134880 T1 AT E134880T1
- Authority
- AT
- Austria
- Prior art keywords
- immune complexes
- binding
- modified forms
- contacting
- reactive protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3687—Chemical treatment
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17692388A | 1988-04-04 | 1988-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE134880T1 true ATE134880T1 (de) | 1996-03-15 |
Family
ID=22646454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89904944T ATE134880T1 (de) | 1988-04-04 | 1989-03-31 | Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0411017B1 (de) |
AT (1) | ATE134880T1 (de) |
AU (1) | AU633488B2 (de) |
CA (1) | CA1339290C (de) |
DE (1) | DE68925899T2 (de) |
WO (1) | WO1989009628A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2015515C (en) * | 1990-01-03 | 1999-12-07 | Jean-Marie Saint-Remy | Pharmaceutical compositions containing antigen-antibody complexes and uses therefor |
US5162515A (en) * | 1990-01-16 | 1992-11-10 | La Jolla Pharmaceutical Company | Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
US5221628A (en) * | 1991-03-19 | 1993-06-22 | Northwestern University | Binding of aggregated immunoglobulin or immune complexes by serum amyloid P component |
US5405832A (en) * | 1991-11-27 | 1995-04-11 | Immtech International Inc. | Method of treating non-streptococcal bacterial infections |
US5874238A (en) * | 1993-02-26 | 1999-02-23 | Immtech International Inc. | Mutant protein and methods and materials for making and using it |
ATE189394T1 (de) * | 1991-11-27 | 2000-02-15 | Immtech Int Inc | Methode zur behandlung von viralen infektionen |
US5283238A (en) * | 1992-04-24 | 1994-02-01 | Immtech International, Inc. | Methods of treating cancer using modified C-reactive protein |
AU6252294A (en) * | 1993-02-26 | 1994-09-14 | Immtech International, Inc. | A mutant protein and methods and materials for making and using it |
US6703219B1 (en) | 1993-02-26 | 2004-03-09 | Immtech International Inc. | Mutant protein and methods and materials for making and using it |
US5753227A (en) * | 1993-07-23 | 1998-05-19 | Strahilevitz; Meir | Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases |
US5547931A (en) * | 1994-02-23 | 1996-08-20 | Immtech International Inc. | Methods of stimulatory thrombocytopoiesis using modified C-reactive protein |
US6429017B1 (en) | 1999-02-04 | 2002-08-06 | Biomerieux | Method for predicting the presence of haemostatic dysfunction in a patient sample |
US6898532B1 (en) | 1995-06-07 | 2005-05-24 | Biomerieux, Inc. | Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample |
US5874409A (en) | 1995-06-07 | 1999-02-23 | La Jolla Pharmaceutical Company | APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies |
US6321164B1 (en) | 1995-06-07 | 2001-11-20 | Akzo Nobel N.V. | Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade |
US6502040B2 (en) | 1997-12-31 | 2002-12-31 | Biomerieux, Inc. | Method for presenting thrombosis and hemostasis assay data |
US6858210B1 (en) | 1998-06-09 | 2005-02-22 | La Jolla Pharmaceutical Co. | Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same |
EP1147423B1 (de) | 1999-02-04 | 2004-11-10 | bioMérieux, Inc. | Verfahren und vorrichtung zum vorhersagen von haemostatischer funktionsstörung in patientenproben |
US6251624B1 (en) | 1999-03-12 | 2001-06-26 | Akzo Nobel N.V. | Apparatus and method for detecting, quantifying and characterizing microorganisms |
US7179612B2 (en) | 2000-06-09 | 2007-02-20 | Biomerieux, Inc. | Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality |
DE10117043A1 (de) * | 2001-04-05 | 2002-11-07 | Gerhard Puetz | Verfahren zur Eliminierung von potentiell toxischen und/oder schädlichen Stoffen |
US6872541B2 (en) * | 2001-07-25 | 2005-03-29 | Coulter International Corp. | Method and compositions for analysis of pentraxin receptors as indicators of disease |
DE10226011A1 (de) * | 2002-06-12 | 2004-01-08 | Aventis Pharma Deutschland Gmbh | HTS-fähiges Verfahren und Testsystem zur Ermittlung der Wechselwirkung zwischen c-reaktivem Protein und an C-reaktives Protein bindenden Komponenten |
CN105388292A (zh) * | 2015-10-19 | 2016-03-09 | 清华大学深圳研究生院 | 试剂盒及联合检测pct、crp及il-6的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4617262A (en) * | 1983-07-22 | 1986-10-14 | Cooperbiomedical, Inc. | Assaying for circulating immune complexes with labeled protein A |
US4551435A (en) * | 1983-08-24 | 1985-11-05 | Immunicon, Inc. | Selective removal of immunospecifically recognizable substances from solution |
US4801449A (en) * | 1985-01-11 | 1989-01-31 | Imre Corporation | Method for treatment of Kaposi's sarcoma |
-
1989
- 1989-03-31 AT AT89904944T patent/ATE134880T1/de active
- 1989-03-31 WO PCT/US1989/001247 patent/WO1989009628A1/en active IP Right Grant
- 1989-03-31 AU AU34485/89A patent/AU633488B2/en not_active Ceased
- 1989-03-31 EP EP89904944A patent/EP0411017B1/de not_active Expired - Lifetime
- 1989-03-31 DE DE68925899T patent/DE68925899T2/de not_active Expired - Fee Related
- 1989-04-03 CA CA000595543A patent/CA1339290C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0411017B1 (de) | 1996-03-06 |
DE68925899T2 (de) | 1996-10-02 |
AU633488B2 (en) | 1993-02-04 |
DE68925899D1 (de) | 1996-04-11 |
CA1339290C (en) | 1997-08-12 |
AU3448589A (en) | 1989-11-03 |
EP0411017A1 (de) | 1991-02-06 |
WO1989009628A1 (en) | 1989-10-19 |
EP0411017A4 (en) | 1991-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE134880T1 (de) | Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen | |
ATE182625T1 (de) | Rekombinante anti-vla4 antikörpermoleküle | |
ATE98776T1 (de) | Monoklonale antikoerper fuer hba1c. | |
ES2145924T3 (es) | Procedimiento para detectar anticuerpos. | |
NO821431L (no) | Fremgangsmaate og sett for proeving av antilegemer mot antigener | |
ATE121788T1 (de) | Blutgerinnungsfaktor beta xiia monoklonale antikörper und immunanalyse. | |
NO175639C (no) | Peptid, antistoff oppnådd ved hjelp av peptidet, en fremgangsmåte for immunologisk bestemmelse av intakt prokollagen peptid (type III) og anvendelse av peptidet | |
DE69200460D1 (de) | Agglutinationskomplex zum Nachweis von Blutgruppen. | |
ATE105086T1 (de) | Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b. | |
DE69026875D1 (de) | Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür | |
GB2233091A (en) | Immunoassays using monoclonal antibodies directed against natural binding proteins | |
ATE73463T1 (de) | Monoklonale antikoerper. | |
DK608789D0 (da) | Cea-immunanalyse uden falske positive foraarsaget af humant anti-museantistof | |
NO972046D0 (no) | Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike | |
ITMI930477A1 (it) | Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio | |
SE8705137D0 (sv) | Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method | |
ATE64466T1 (de) | Immuntest. | |
SE9700745D0 (sv) | Improved immunoassays and improved diagnostic methods and a kit to be used in the methods | |
FI102217B1 (fi) | Menetelmä Pseudomonas aeruginosa-serotyyppien toteamiseksi näytteestä in vitro monoklonaalisten vasta-aineiden avulla, menetelmässä käytettäviä monoklonaalisia vasta-aineita sekä menetelmässä käyttökelpoinen testipakkaus |